Human Molecular Genetics Advance Access originally published online on May 11, 2005
Human Molecular Genetics 2005 14(13):1839-1850; doi:10.1093/hmg/ddi190
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma

1Department of Medical Genetics, Cardiff University, Heath Park, Cardiff CF14 4XN, UK, 2Department of Pathology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK and 3Gene Targeting Laboratory, Institute for Stem Cell Research, University of Edinburgh, The King's Buildings, West Mains Road, Edinburgh EH9 3JQ, UK
* To whom correspondence should be addressed. Tel: +44 2920742652; Fax: +44 2920746551; Email: cheadlejp{at}cardiff.ac.uk
Received March 17, 2005; Accepted May 6, 2005
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in either the TSC1 or the TSC2 genes and characterized by the development of benign hamartomatous growths in multiple organ systems. We have inactivated Tsc1 in the mouse germ line by gene targeting in ES cells and confirmed that the mutant allele (Tsc1) has a recessive embryonic lethal phenotype. We found that a significant number (
27%) of heterozygous (Tsc1+/) mice on the C57BL/6 background died before weaning (P=0.014) and show that these mice die in the post-natal period (P=0.033), normally at 12 days, from unknown causes. Forty-four percent (7/16) of Tsc1+/ mice on a C3H background developed macroscopically visible renal lesions as early as 36 months, increasing to 95% (37/39) by 1518 months. Renal lesions progressed from cysts through cystadenomas to solid carcinomas. Eighty percent (16/20) of Tsc1+/ mice on a Balb/c background exhibited solid renal cell carcinomas (RCC) by 1518 months and in 41%, RCCs were
5 mm, resulting in grossly deformed kidneys. Some RCCs had a sarcomatoid morphology of spindle cells in whorled patterns and metastasized to the lungs. We detected loss of the wild-type Tsc1 allele and elevated levels of p-mTOR and p-S6 in lesions from Tsc1+/ mice. This new murine model of hamartin deficiency exhibits a more severe phenotype than existing models.
Present address: MRC Human Reproductive Sciences Unit, Centre for Reproductive Biology, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Zhou, J. Brugarolas, and L. F. Parada Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1 Hum. Mol. Genet., November 15, 2009; 18(22): 4428 - 4441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pollizzi, I. Malinowska-Kolodziej, C. Doughty, C. Betz, J. Ma, J. Goto, and D. J. Kwiatkowski A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles Hum. Mol. Genet., July 1, 2009; 18(13): 2378 - 2387. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bonnet, M. Aldred, C. von Ruhland, R. Harris, R. Sandford, and J. P. Cheadle Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis Hum. Mol. Genet., June 15, 2009; 18(12): 2166 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Way, J. McKenna III, U. Mietzsch, R. M. Reith, H. C.-j. Wu, and M. J. Gambello Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse Hum. Mol. Genet., April 1, 2009; 18(7): 1252 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Clements, S. L Asprey, T. A McCulloch, T. A Morris, S. A Watson, and S. R Johnson Analysis of the oestrogen response in an angiomyolipoma derived xenograft model Endocr. Relat. Cancer, March 1, 2009; 16(1): 59 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hossain, S. M. Ali, H. L. Ko, J. Xu, C. P. Ng, K. Guo, Z. Qi, S. Ponniah, W. Hong, and W. Hunziker Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1 PNAS, January 30, 2007; 104(5): 1631 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wilson, C. Bonnet, C. Guy, S. Idziaszczyk, J. Colley, V. Humphreys, J. Maynard, J. R. Sampson, and J. P. Cheadle Tsc1 Haploinsufficiency without Mammalian Target of Rapamycin Activation Is Sufficient for Renal Cyst Formation in Tsc1+/- Mice Cancer Res., August 15, 2006; 66(16): 7934 - 7938. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Goncharova, D. A. Goncharov, P. N. Lim, D. Noonan, and V. P. Krymskaya Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wilson, S. Idziaszczyk, J. Colley, V. Humphreys, C. Guy, J. Maynard, J. R. Sampson, and J. P. Cheadle Induction of Renal Tumorigenesis with Elevated Levels of Somatic Loss of Heterozygosity in Tsc1+/- Mice on a Blm-Deficient Background Cancer Res., November 15, 2005; 65(22): 10179 - 10182. [Abstract] [Full Text] [PDF] |
||||




